AbCellera and Rallybio Announce Strategic Alliance to Discover, Develop, and Commercialize Novel Antibody-Based Therapeutics for Rare Diseases-biotech.vision

AbCellera and Rallybio Announce Strategic Alliance to Discover, Develop, and Commercialize Novel Antibody-Based Therapeutics for Rare Diseases

In order to find, create, and market innovative antibody-based therapies for rare illnesses, AbCellera and Rallybio…

Continue Reading
Agilent Attains ‘Angel’ Level Sponsorship with My Green Lab-biotech.vision

Agilent Attains ‘Angel’ Level Sponsorship with My Green Lab

My Green Lab, a nonprofit organization devoted to fostering a global culture of sustainability in research,…

Continue Reading
Pictor announces funding round after successful launch in New Zealand and USA of SARS-CoV-2 Antibody Test-biotech.vision

Pictor announces funding round after successful launch in New Zealand and USA of SARS-CoV-2 Antibody Test

 Pictor, a leader in immunodiagnostics, launched a fundraising round to hasten pipeline product development projects and…

Continue Reading
Envisagenics Announces Research Collaboration with Bristol Myers Squibb-bioech.vision

Envisagenics Announces Research Collaboration with Bristol Myers Squibb

Envisagenics, a biotechnology company powered by artificial intelligence that develops treatments for RNA splicing disorders, has…

Continue Reading
IPA’s Subsidiary BioStrand and BriaCell Announce Artificial Intelligence Collaboration and License Agreement-biotech.vision

IPA’s Subsidiary BioStrand and BriaCell Announce Artificial Intelligence Collaboration and License Agreement

IPA, a leading biotherapeutics research and technology company, announced that BioStrand BV for IPA’s AI in…

Continue Reading
Rocket Pharmaceuticals Completes Acquisition of Renovacor-biotech.vision

Rocket Pharmaceuticals Completes Acquisition of Renovacor

Rocket Pharmaceuticals, Inc. a leading early-stage biotechnology company developing an integrated and sustainable gene therapy pipeline…

Continue Reading
BigHat Biosciences Announces Research Collaboration with Merck-biotech.vision

BigHat Biosciences Announces Research Collaboration with Merck

The biotechnology firm BigHat Biosciences, Inc., which has a platform for machine learning-guided antibody discovery and…

Continue Reading
Cimeio Therapeutics Announces Issuance of Key Patent Covering Cell Therapy Platform-biotech.vision

Cimeio Therapeutics Announces Issuance of Key Patent Covering Cell Therapy Platform

Cimeio Therapeutics, a biotechnology company developing a new approach to cell therapy, today announced that the…

Continue Reading
Bionaut Labs Closes $43M in Series B Led by Khosla Ventures to Advance First-in-Class Micro-Robotic Technology and Remove Barriers-biotech.vision

Bionaut Labs Closes $43M in Series B Led by Khosla Ventures to Advance First-in-Class Micro-Robotic Technology and Remove Barriers

Bionaut Labs, a company that uses tiny robots to revolutionize the treatment of central nervous system…

Continue Reading
Biocytogen Enters into Antibody Agreement with ADC Therapeutics-biotech.vision

Biocytogen Enters into Antibody Agreement with ADC Therapeutics

ADC Therapeutics SA and Biocytogen Pharmaceuticals Co., Ltd. announced that they had signed an assessment and…

Continue Reading